US 7875292
Orally disintegrable tablets
granted A61KA61K31/4439A61K9/0056
Quick answer
US patent 7875292 (Orally disintegrable tablets) held by Takeda Pharmaceutical Company Limited expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4439, A61K9/0056, A61K9/1611, A61K9/1652